Gemcitabine and carfilzomib induced thrombotic microangiopathy: eculizumab as a life‐saving treatment

Drug‐induced aHUS is rare; however, early diagnosis is vital to reduce morbidity and mortality. With confirmation of the diagnosis, eculizumab appears to be a viable treatment option to suppress the pro‐inflammatory surge. Furthermore, adverse side effects of medications such as carfilzomib and gemc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Case Rep
Asıl Yazarlar: Gosain, Rahul, Gill, Amitoj, Fuqua, Jacob, Volz, Lesley H., Kessans Knable, Mika R., Bycroft, Ryan, Seger, Sarah, Gosain, Rohit, Rios, Jorge A., Chao, Ju‐Hsien
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2017
Konular:
Case Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5715608/
https://ncbi.nlm.nih.gov/pubmed/29225827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1214
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller